114 machine-learning-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"Linköpings-University" positions at City of Hope in United States
Sort by
Refine Your Search
-
, is a transplant and CAR T cell immunology laboratory at City of Hope. The lab has an outstanding academic environment focused on immunology, microbiota and bone marrow transplantation and has a strong
-
, or designee, the Research Associate I will perform a variety of research experiments. The van den Brink Laboratory, is a transplant and CAR T cell immunology laboratory at City of Hope. The lab has
-
the endogenous immune system. We use this information to design solid-tumor targeted CAR effector cells with improved persistence and potency, as well as the ability to amplify the antitumor immune response. As a
-
for publication. Preferred qualifications: Experience with super-resolution microscopy, coding (Phyton, Matlab), and machine learning is preferred. City of Hope employees pay is based on the following criteria
-
supervisors’ direction to complete tasks. Utilize City of Hope resources (computer, phone, office equipment) as directed by supervisor. Work closely with assigned team members to complete assigned tasks
-
Oncology Department at City of Hope is the largest Radiation Oncology enterprise in the southern California with more than 25 Linear Accelerators (Linacs) including special designed machines such as MR
-
of induced pluripotent stem cell-based human disease models 2) Understanding the role of immunity during tumorigenesis as well as disease relapses in order to design novel inhibitors, CAR-T cell therapy and
-
involves developing and application of interpretable machine learning methods combined with physics based molecular dynamics simulations to uncover allosteric regulation of disordered regions in the dynamics
-
communication and problem-solving skills and able to function independently and proficiently · Demonstrable computer skills in Microsoft Word, Excel, and/or Microsoft Access as well as skills in data
-
people that focuses primarily on autologous production of >60 CAR-T therapies per year in support of early clinical trials. Additional relevant areas of expertise are manufacturing of TILs and CAR-NK. As a